Renaissance Capital’s CureVac CVAC Stock Holding History

Renaissance Capital’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,668	Closed	-$327K	–	82
2022 Q1	$327K	Sell	16,668 -4,991	-23%	-$99.7K	0.14%	87
2021 Q4	$743K	Sell	21,659 -3,795	-15%	-$153K	0.19%	78
2021 Q3	$1.39M	Sell	25,454 -31,461	-55%	-$1.9M	0.28%	61
2021 Q2	$4.18M	Sell	56,915 -67,068	-54%	-$6.7M	0.66%	35
2021 Q1	$11.3M	Buy	123,983 +98,967	+396%	+$9.6M	1.68%	19
2020 Q4	$2.03M	Buy	+25,016	New	+$1.92M	0.28%	42

Other funds holding CVAC

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Renaissance Capital's CVAC Position: Q2 2022 in Review

Renaissance Capital sold out of CureVac (CVAC) in Q2 2022, closing a stake of 16,668 shares — an estimated $327K sold.

Renaissance Capital first reported a position in CVAC in Q4 2020 and held it in 6 quarters. The position peaked at $11.3M in Q1 2021. 88 funds tracked by Wall St. Rank hold CVAC as of Q2 2022.

Renaissance Capital reported no remaining CureVac position as of Q2 2022 after selling out during the quarter.
Renaissance Capital sold 16,668 CureVac shares in Q2 2022, an estimated $327K.
Renaissance Capital first reported a position in CureVac in Q4 2020 and held it in 6 quarters.
Renaissance Capital's CureVac position peaked at $11.3M in Q1 2021.
88 funds tracked by Wall St. Rank held CureVac as of Q2 2022.

Based on Renaissance Capital's 13F filing for Q2 2022, filed 11 Jul 2022.